new stock recommendation

[New Stock Reco]: Expecting profit to double in the next 4 years

September 30, 2023

Hello Sir, Hope you are doing well. We have released our new stock recommendation for our Alpha and Alpha + Members and would like to share with you details on the same. We focus on growth oriented, owner operated, leading companies in their respective segments that are trading at reasonable valuations and invest with a horizon of 3-4 years. The one shared on Friday fits our framework as it’s a sub Rs 2,500 crore market cap stock, among the top 2 players…

[New Stock Reco]: Management targeting 30% + growth in sales in FY 24

August 4, 2023

Hello Sir, Hope you are doing well. On 29th Jul’23, Saturday evening, we released our new stock recommendation for our (opens in new tab)Alpha and Alpha + Members. As per the management, for FY 24 they are hoping to achieve 30% + growth in sales at around Rs 1,200 crore with EBITDA margins of around 18-20%. If the management is able to achieve the above numbers, the operating profit of the company will see a jump of ~75% in FY 24 over…

[New Stock Report]: Sub 500 crore market cap, deleveraging and ~6 times post-tax earnings

April 1, 2023

Hello Sir,Hope you are doing well.Yesterday, we released our new stock recommendation for our Alpha and Alpha + Members and would like to share with you details on the same.We focus on growth oriented small-mid cap companies that are trading at reasonable valuations and invest with a horizon of 3-4 years.The one shared yesterday fits our framework as despite being a sub 500 crore market cap stock, it’s one of the largest players in its segment, has good operating performance track record,…

[New Stock Reco]: Expecting profit to double in the next 4 years

[New Stock Reco]: Management targeting 30% + growth in sales in FY 24

[New Stock Report]: Sub 500 crore market cap, deleveraging and ~6 times post-tax earnings

[New Stock Reco]: Pharma Company, net debt free and around 11-12 times earnings